Abstract
Efficacy of certain biologics for treatment of chronic rhinosinusitis with nasal polyps (CRSwNP) or asthma is well documented, however there has been less research performed for asthma outcomes for patients with both asthma and chronic rhinosinusitis (CRS). We aimed to study improvement in asthma control for patients with concurrent asthma and CRS (asthma+CRS) after initiation of a biologic treatment, and to investigate whether the presence of nasal polyps, demographic factors, or other presence of atopic conditions impacts response to asthma biologics.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
